{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:26:43Z","timestamp":1778016403951,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.neuropharm.2006.06.013","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T12:34:14Z","timestamp":1155126854000},"page":"1004-1012","source":"Crossref","is-referenced-by-count":61,"title":["The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum"],"prefix":"10.1016","volume":"51","author":[{"given":"A.","family":"Pintor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Tebano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Martire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Scattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e8zzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Coccurello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Felici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Calamandrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.06.013_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiology Disease"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0301-0082(99)00032-5","article-title":"Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's disease","volume":"60","author":"Alexi","year":"2000","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1006\/mcne.2001.0992","article-title":"Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission","volume":"17","author":"Battaglia","year":"2001","journal-title":"Molecular Cellular Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1124\/mol.60.1.155","article-title":"Evidence for a new G protein-coupled cannabinoid receptor in mouse brain","volume":"60","author":"Breivogel","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib7","doi-asserted-by":"crossref","first-page":"11073","DOI":"10.1523\/JNEUROSCI.23-35-11073.2003","article-title":"Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake","volume":"23","author":"Brown","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib8","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1523\/JNEUROSCI.17-12-04509.1997","article-title":"Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses","volume":"17","author":"Calabresi","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0028-3908(02)00080-1","article-title":"Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for\u00a0the\u00a0attenuation of post-ischemic injury and epileptiform activity?","volume":"43","author":"Cozzi","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jnr.1224","article-title":"Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels","volume":"66","author":"Ferraro","year":"2001","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiology Reviews"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","article-title":"Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus","volume":"106","author":"Hajos","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib16","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proceedings National Academy of Science U S A"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","article-title":"Neuronal localization of cannabinoid receptors in the basal ganglia of the rat","volume":"547","author":"Herkenham","year":"1991","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","article-title":"Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons","volume":"532","author":"Huang","year":"2001","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib19","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1460-9568.2003.02897.x","article-title":"Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action","volume":"18","author":"Kofalvi","year":"2003","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib20","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"25","author":"Kofalvi","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00001756-200305060-00007","article-title":"Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate","volume":"14","author":"Lastres-Becker","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1152\/jn.1993.70.4.1451","article-title":"Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus","volume":"70","author":"Manabe","year":"1993","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib25","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.2002.6635","article-title":"Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice","volume":"292","author":"Monory","year":"2002","journal-title":"Biochemistry Biophysics Research Communication"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacology Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib30","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.WNL.0000095216.89483.A2","article-title":"Modulation of glutamate release and excitotoxicity by adenosine A2A receptors","volume":"61","author":"Popoli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1471-4159.2004.02448.x","article-title":"Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity","volume":"89","author":"Popoli","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00253-X","article-title":"The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects","volume":"95","author":"Romero","year":"2002","journal-title":"Pharmacology Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbr.2003.10.021","article-title":"Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease","volume":"152","author":"Scattoni","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib35","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1523\/JNEUROSCI.14-09-05325.1994","article-title":"Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation","volume":"14","author":"Schulz","year":"1994","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.06.013_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(02)02148-9","article-title":"SCH 58261 differentially\u00a0influences quinolinic acid-induced effects in striatal and in hippocampal slices","volume":"450","author":"Tebano","year":"2002","journal-title":"European Journal of Pharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806001948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806001948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T15:59:32Z","timestamp":1555775972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806001948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0028390806001948"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.06.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}